SCHEMBL3846054

SCHEMBL3846054

O=C(NC1CC1)c1ccc(-c2ncnc3ccc(Cl)cc23)cc1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 2/20 0.46
PDK2 Q15119 1/20 0.46
PDK3 Q15120 1/20 0.46
PDK4 Q16654 1/20 0.46
HPGD P15428 2/20 0.44
PIK3CA P42336 1/20 0.42
MTOR P42345 1/20 0.42
CAMKK1 Q8N5S9 1/20 0.42
CAMKK2 Q96RR4 1/20 0.42
USP30 Q70CQ3 1/20 0.42
PDE2A O00408 2/20 0.42
PDE10A Q9Y233 2/20 0.42
MAPK1 P28482 3/20 0.41
CNR1 P21554 2/20 0.41
CNR2 P34972 1/20 0.41
KCNH2 Q12809 1/20 0.41
GPR119 Q8TDV5 1/20 0.41
ALDH1A1 P00352 1/20 0.41
PDE4B Q07343 2/20 0.41
PDE4D Q08499 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3844913 0.82 PDK1 (0.50) PDK1PDK2PDK3PDK4HPGD
SCHEMBL19947326 0.78 HPGD (0.63) HPGDCNR1CNR2ALDH1A1PDE4B
Hydrochloric Acid SCHEMBL3854414 0.77 DYRK1A (0.42) HPGDPIK3CAMTORCAMKK1CAMKK2
SCHEMBL3847833 0.76 DHODH (0.50) PDK1PDK2PDK3PDK4HPGD
SCHEMBL3846537 0.76 CAMKK1 (0.48) PDK1PDK2PDK3PDK4CAMKK1
SCHEMBL13874574 0.75 MAP4K4 (0.37) HPGDPIK3CAMTORCAMKK1CAMKK2
SCHEMBL14082780 0.75 HPGD (0.51) HPGDUSP30PDE4BPDE4D
SCHEMBL3850684 0.73 ALOX5AP (0.39) PIK3CAMTORCAMKK1CAMKK2USP30
SCHEMBL3845659 0.72 TAS1R3 (0.53) HPGDMAPK1ALDH1A1
SCHEMBL14145475 0.72 MAP4K4 (0.50) PDK1PDK2PDK3PDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed